CMPS News and Press, COMPASS Pathways Plc From 05/23/24

2024-05-23 12:15:00 ET Summary Regulatory risk in the psychedelic industry is decreasing, which is a positive sign for investors. Institutional investors are becoming more willing to invest in leading psychedelic companies through private placements. Analyst Alex Carchidi disc...

Governor Wes Moore of Maryland recently signed two measures into law that will create a task force to conduct research on legal access to psychedelics such as DMT and psilocybin. This move comes almost a month after legislators forwarded the bills to the governor’s desk. The new law wi...

2024-05-21 08:05:00 ET As a psychedelic therapy developer, Compass Pathways (NASDAQ: CMPS) is on the cutting edge of innovation in treating mood disorders. That makes it an exciting, if quite risky, investment. But a lot of that risk burden could be alleviated soon, thanks to a ...

2024-05-11 17:31:10 ET COMPASS Pathways plc (CMPS) Q1 2024 Results Conference Call May 08, 2024 08:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Guy Goodwin - Chief Medical Officer Teri Loxam - CFO Conference Call Participants...

2024-05-10 00:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Depression is a leading cause of disability that affects roughly 300 million individuals around the globe. Now, new research has determined that psilocybin is an effective treatment for symptoms of depression. This is in comparison to niacin, which was administered as the placebo, and microdose...

2024-05-09 04:45:11 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q1 2024 Earnings Call May 08, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Tr...

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

2024-05-08 06:52:20 ET More on COMPASS Pathways ADS COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut? COMPASS Pathways plc (CMPS) Q4 2023 Earnings Call Transcript Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrari...

COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, COMP006 trial top-line data expected mid-2025 Compass announces positive phase 2 COMP360 data in post-traumatic stress disorder (PTSD) Michael G...